287 related articles for article (PubMed ID: 26954520)
1. Survival of smear-positive multidrug resistant tuberculosis patients in Witbank, South Africa: A retrospective cohort study.
Olaleye AO; Beke AK
Infect Dis (Lond); 2016; 48(6):422-7. PubMed ID: 26954520
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
[TBL] [Abstract][Full Text] [Related]
3. [Survival time and influencing factors in multidrug-resistant tuberculosis patients in Wuhan, 2006-2014].
Wang JJ; Zhou ML; Chen C; Wu G; Zuo YP; Ren X; Chen Z; Wang WH
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1409-1413. PubMed ID: 31838813
[No Abstract] [Full Text] [Related]
4. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
Kliiman K; Altraja A
Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
[TBL] [Abstract][Full Text] [Related]
5. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
Atalell KA; Birhan Tebeje N; Ekubagewargies DT
PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
[TBL] [Abstract][Full Text] [Related]
6. Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: A retrospective follow-up study.
Woldeyohannes D; Tekalegn Y; Sahiledengle B; Assefa T; Aman R; Hailemariam Z; Mwanri L; Girma A
PLoS One; 2021; 16(5):e0250804. PubMed ID: 33956812
[TBL] [Abstract][Full Text] [Related]
7. Survival model analysis of tuberculosis treatment among patients with human immunodeficiency virus coinfection.
Azeez A; Mutambayi R; Odeyemi A; Ndege J
Int J Mycobacteriol; 2019; 8(3):244-251. PubMed ID: 31512600
[TBL] [Abstract][Full Text] [Related]
8. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
[TBL] [Abstract][Full Text] [Related]
9. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.
Heller T; Lessells RJ; Wallrauch CG; Bärnighausen T; Cooke GS; Mhlongo L; Master I; Newell ML
Int J Tuberc Lung Dis; 2010 Apr; 14(4):420-6. PubMed ID: 20202299
[TBL] [Abstract][Full Text] [Related]
10. Predictors of mortality in a cohort of tuberculosis/HIV co-infected patients in Southwest Ethiopia.
Gesesew H; Tsehayneh B; Massa D; Gebremedhin A; Kahsay H; Mwanri L
Infect Dis Poverty; 2016 Dec; 5(1):109. PubMed ID: 27915999
[TBL] [Abstract][Full Text] [Related]
11. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
12. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
[TBL] [Abstract][Full Text] [Related]
13. Predictors of death among drug-resistant tuberculosis patients in Kuala Lumpur, Malaysia: A retrospective cohort study from 2009 to 2013.
Mohd Shariff N; Shah SA; Kamaludin F
J Glob Antimicrob Resist; 2016 Sep; 6():102-107. PubMed ID: 27530850
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia.
Alene KA; Viney K; McBryde ES; Tsegaye AT; Clements AC
Trop Med Int Health; 2017 Mar; 22(3):351-362. PubMed ID: 27978594
[TBL] [Abstract][Full Text] [Related]
15. Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa.
Schnippel K; Firnhaber C; Ndjeka N; Conradie F; Page-Shipp L; Berhanu R; Sinanovic E
Int J Tuberc Lung Dis; 2017 Oct; 21(10):1106-1111. PubMed ID: 28911353
[TBL] [Abstract][Full Text] [Related]
16. Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis/HIV coinfected patients with drug-resistant tuberculosis.
Azeez A; Ndege J; Mutambayi R
Int J Mycobacteriol; 2018; 7(4):347-354. PubMed ID: 30531033
[TBL] [Abstract][Full Text] [Related]
17. Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
Abebe M; Atnafu A; Tilahun M; Sero N; Neway S; Alemu M; Tesfaye G; Mihret A; Bobosha K; Wan C
PLoS One; 2024; 19(5):e0304507. PubMed ID: 38820260
[TBL] [Abstract][Full Text] [Related]
18. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.
Oladimeji O; Isaakidis P; Obasanya OJ; Eltayeb O; Khogali M; Van den Bergh R; Kumar AM; Hinderaker SG; Abdurrahman ST; Lawson L; Cuevas LE
PLoS One; 2014; 9(4):e94393. PubMed ID: 24722139
[TBL] [Abstract][Full Text] [Related]
19. Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia--an observational cohort study.
Meressa D; Hurtado RM; Andrews JR; Diro E; Abato K; Daniel T; Prasad P; Prasad R; Fekade B; Tedla Y; Yusuf H; Tadesse M; Tefera D; Ashenafi A; Desta G; Aderaye G; Olson K; Thim S; Goldfeld AE
Thorax; 2015 Dec; 70(12):1181-8. PubMed ID: 26506854
[TBL] [Abstract][Full Text] [Related]
20. High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa.
Hirasen K; Berhanu R; Evans D; Rosen S; Sanne I; Long L
PLoS One; 2018; 13(10):e0205463. PubMed ID: 30300403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
